270 related articles for article (PubMed ID: 30271152)
1. Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients.
Suda A; Hattori S; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Hirayasu Y
Neuropsychiatr Dis Treat; 2018; 14():2361-2366. PubMed ID: 30271152
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics.
Misawa F; Kishimoto T; Hagi K; Kane JM; Correll CU
Schizophr Res; 2016 Oct; 176(2-3):220-230. PubMed ID: 27499361
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey.
Misawa F; Amemiya A; Fujii Y; Takeuchi H
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):81-86. PubMed ID: 34668878
[TBL] [Abstract][Full Text] [Related]
5. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
[TBL] [Abstract][Full Text] [Related]
6. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
[TBL] [Abstract][Full Text] [Related]
8. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
Miyamoto S; Wolfgang Fleischhacker W
Curr Treat Options Psychiatry; 2017; 4(2):117-126. PubMed ID: 28580230
[TBL] [Abstract][Full Text] [Related]
9. Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Noguchi N; Furuno T; Asami T; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Saeki T; Fukushima T; Moritani T; Saigusa Y; Hishimoto A
BMC Psychiatry; 2023 Mar; 23(1):135. PubMed ID: 36869320
[TBL] [Abstract][Full Text] [Related]
10. Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Ostuzzi G; Bertolini F; Del Giovane C; Tedeschi F; Bovo C; Gastaldon C; Nosé M; Ogheri F; Papola D; Purgato M; Turrini G; Correll CU; Barbui C
Am J Psychiatry; 2021 May; 178(5):424-436. PubMed ID: 33596679
[TBL] [Abstract][Full Text] [Related]
11. Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019.
Peters L; Krogmann A; von Hardenberg L; Bödeker K; Nöhles VB; Correll CU
Curr Psychiatry Rep; 2019 Nov; 21(12):124. PubMed ID: 31745659
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pharmacokinetics and pharmaceutical forms of long-acting injectable antipsychotics].
Kyziridis TC
Psychiatriki; 2022 Jun; 33(2):139-148. PubMed ID: 34390562
[TBL] [Abstract][Full Text] [Related]
13. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.
Kishimoto T; Robenzadeh A; Leucht C; Leucht S; Watanabe K; Mimura M; Borenstein M; Kane JM; Correll CU
Schizophr Bull; 2014 Jan; 40(1):192-213. PubMed ID: 23256986
[TBL] [Abstract][Full Text] [Related]
14. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
Novakovic V; Adel T; Peselow E; Lindenmayer JP
Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
[TBL] [Abstract][Full Text] [Related]
15. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
[TBL] [Abstract][Full Text] [Related]
16. Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia.
Kishi T; Sakuma K; Okuya M; Iwata N
J Psychiatr Res; 2021 Jan; 132():144-150. PubMed ID: 33096355
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.
Lin CH; Chen FC; Chan HY; Hsu CC
Am J Geriatr Psychiatry; 2020 Jan; 28(1):23-30. PubMed ID: 31481273
[TBL] [Abstract][Full Text] [Related]
18. Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials.
Kishi T; Matsunaga S; Iwata N
Schizophr Bull; 2016 Nov; 42(6):1438-1445. PubMed ID: 27086079
[TBL] [Abstract][Full Text] [Related]
19. Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Misawa F; Fujii Y; Takeuchi H
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35921512
[No Abstract] [Full Text] [Related]
20. Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan.
Okada Y; Inada K; Akazawa M
Schizophr Res; 2023 Feb; 252():300-308. PubMed ID: 36706475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]